P

Protagonist Therapeutics
D

PTGX

135.350
USD
-2.84
(-2.06%)
قبل الجلسة·138.990USD+3.640(+2.69%)
حجم التداول
28,594
الربح لكل سهم
5
العائد الربحي
-
P/E
-75
حجم السوق
8,704,544,336
أصول ذات صلة المقالات
المزيد

العنوان: Protagonist Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.